ATRA
ATRA
NASDAQ · Biotechnology

Atara Biotherapeutics Inc

$11.48
+0.31 (+2.78%)
As of Jun 30, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
83.20M
Net Income
22.52M
Gross Margin
82.4%
Profit Margin
27.1%
Rev Growth
+23.9%
D/E Ratio
0.04
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 82.4% 82.4% 58.2% 58.2%
Operating Margin 29.7% 26.7% -3.7% -3.7%
Profit Margin 27.1% 25.7% -2.9% -3.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 83.20M 67.18M 4.60M 4.74M
Gross Profit 68.59M 55.38M 2.67M 2.76M
Operating Income 24.70M 17.95M -170,760 -175,722
Net Income 22.52M 16.36M -132,709 -155,737
Gross Margin 82.4% 82.4% 58.2% 58.2%
Operating Margin 29.7% 26.7% -3.7% -3.7%
Profit Margin 27.1% 25.7% -2.9% -3.3%
Rev Growth +23.9% +23.9% -8.7% +11.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.58M 1.58M 15.40M 16.39M
Total Equity 44.46M 44.46M 18.11M 18.20M
D/E Ratio 0.04 0.04 0.85 0.90
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 26.16M 20.07M -214,542 -195,381
Free Cash Flow -85,981 -141,773